Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Cost-effectiveness analysis of proton beam therapy for treatment decision making in paranasal sinus and nasal cavity cancers in China

Fig. 3

Cost-effectiveness of IMPT in patients of different age levels. Incremental cost (IE), incremental effectiveness (IC) and incremental cost-effectiveness ratio (ICER) were evaluated by stratified analyses for patients of 0,10, 20, 30, 40, 50, 60, 70-year-old levels to the endpoint of the Chinese life expectancy (77-year-old). IMPT, intensity modulated proton radiation therapy; IMRT, intensity modulated photon-radiation therapy; QALY, quality adjusted life year; WTP: willingness to pay; $, US dollars

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us